Low-Dose Fenfluramine Successful in Treating Dravet Syndrome in Phase 3 Trial
August 1st 2018Fenfluramine, a drug that was previously sold as an appetite suppressant before it was withdrawn from the market in 1997 over concerns about its link to heart valve problems, may have a new application.
Read More